Children born with congenital heart defects may require frequent surgeries that prevent them from living their lives to the fullest. PolyVascular provides the only non-surgical pulmonary valve and delivery system suitable for children as young as 2 years old. Our minimally invasive valve reduces the need for open heart surgery and enables kids to enjoy a healthy, normal lifestyle. Current animal tissue valves often cause endocarditis, while human tissue grafts may sensitize the child's immune system. We address these limitations with our biocompatible, durable, polymer-based valve. Our valve, provided with an-easy-to-use delivery system for clinicians, is easy to manufacture at any size.

Biotechnology

Health Care

Life Sciences

Medical Devices

PolyVascular

PolyVascular's headquarters in Houston, United States

Tim Moran

Mary Bales

Cindy Clague

This department manages communication and relationships between the company and its investors.

Investor Relations

This department focuses on guiding the overall strategic direction and vision of the organization.

Executive Leadership

This department focuses on innovating and advancing product development through research and experimentation.

PolyVascular

Org chart

Teams

Investor Relations

Executive Leadership

Research and Development

Offices

PolyVascular

Org chart

Teams

Investor Relations

Executive Leadership

Research and Development

Offices

Related companies